Triggers of paroxysmal dyskinesia in the calcium channel mouse mutant tottering

Brandy E Fureman1, H A Jinnah, Ellen J Hess

  • 1Department of Neurology, Johns Hopkins University School of Medicine, Meyer Room 6-181, 600 North Wolfe Street, Baltimore, MD 21287, USA.

Insights

The tottering mouse, with a P/Q-type calcium channel mutation, models episodic neurological disorders. Stress, caffeine, and ethanol trigger attacks, suggesting a role for neuronal excitability and calcium influx in these events.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Channelopathies, caused by ion channel mutations, lead to episodic neurological disorders.
  • Attacks in these disorders are often triggered by common stimuli like stress, caffeine, and ethanol.
  • The tottering mouse model exhibits P/Q-type calcium channel mutations and spontaneous dyskinesia attacks.

Purpose of the Study:

  • To validate the tottering mouse as a model for studying episodic neurological disorders.
  • To investigate the role of specific triggers in precipitating attacks in tottering mice.
  • To explore the involvement of calcium influx and neuronal excitability in triggered attacks.

Main Methods:

  • Tottering mice were exposed to environmental stressors, caffeine, and ethanol.
  • The efficacy of L-type calcium channel antagonist nimodipine and NMDA receptor antagonist MK-801 in preventing attacks was assessed.
  • Attacks were monitored following exposure to triggers and drug interventions.

Main Results:

  • Stress, caffeine, and ethanol reliably induced dyskinesia attacks in tottering mice.
  • Nimodipine prevented caffeine- and ethanol-induced attacks.
  • MK-801 prevented stress- and caffeine-induced attacks.

Conclusions:

  • These findings support a common mechanism involving neuronal excitability and calcium influx in attacks triggered by diverse agents.
  • The tottering mouse is a valuable model for investigating the triggers of episodic neurological disorders.
  • Pharmacological interventions targeting calcium channels may offer therapeutic potential for these conditions.

Related Concept Videos